Company · CIK 0001069899 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
PHIBRO ANIMAL HEALTH CORP · PAHC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 AForm 4/A → | Sep 17, 5:33 pm EDT | Glenn DavidChief Financial Officer | 3,482 | — | — | 54,959 | — | |
| Aug 6, 2026 AForm 4/A → | Sep 17, 5:32 pm EDT | Larry Lee MillerChief Operating Officer | 3,726 | — | — | 38,275 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 4:19 pm EDT | Patrick RodriguezVP Finance and Treasurer | 1,503 | — | — | 1,503 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 4:18 pm EDT | Glenn DavidChief Financial Officer | 3,334 | — | — | 54,811 | — | amended |
| Aug 6, 2026 AForm 4 → | Aug 10, 4:17 pm EDT | Larry Lee MillerChief Operating Officer | 3,522 | — | — | 38,071 | — | amended |
| Aug 6, 2026 AForm 4 → | Aug 10, 4:17 pm EDT | Jonathan BendheimDirector | 2,716 | — | — | 5,984 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 4:16 pm EDT | Judith WeinsteinSee Remarks | 2,478 | — | — | 5,453 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 4:16 pm EDT | Jack Bendheim +1Executive Chairman, Director, 10% Owner | 12,103 | — | — | 26,640 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 4:15 pm EDT | Lisa Ann EscuderoSee Remarks | 1,547 | — | — | 3,434 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 4:15 pm EDT | Daniel M BendheimPresident and CEO, Director | 11,699 | — | — | 15,177 | — | |
| Aug 4, 2026 JForm 4 → | Aug 6, 8:12 pm EDT | Jack Bendheim +1Executive Chairman, Director, 10% Owner | 2,303 | $36.60 | $84,287 | 14,537 | — | |
| Aug 4, 2026 JForm 4 → | Aug 6, 8:12 pm EDT | Lisa Ann EscuderoSee Remarks | 265 | $36.60 | $9,699 | 1,887 | — | |
| Aug 4, 2026 JForm 4 → | Aug 6, 8:11 pm EDT | Larry Lee MillerChief Operating Officer | 635 | $36.60 | $23,240 | 34,549 | — | |
| Aug 4, 2026 JForm 4 → | Aug 6, 8:10 pm EDT | Judith WeinsteinSee Remarks | 472 | $36.60 | $17,275 | 2,975 | — | |
| Aug 4, 2026 JForm 4 → | Aug 6, 8:10 pm EDT | Glenn DavidChief Financial Officer | 840 | $36.60 | $30,743 | 51,477 | — | |
| Aug 4, 2026 JForm 4 → | Aug 6, 8:10 pm EDT | Daniel M BendheimPresident and CEO, Director | 486 | $36.60 | $17,787 | 3,478 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 AForm 4 → | Jul 2, 4:15 pm EDT | Daniel M BendheimPresident and CEO, Director | 300,000 | — | — | 300,000 | — |